MIR1225 (microRNA 1225) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: MIR1225 (microRNA 1225) Homo sapiens
Analyze
Symbol: MIR1225
Name: microRNA 1225
RGD ID: 2313002
HGNC Page HGNC
Description: microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Type: ncrna
RefSeq Status: PROVISIONAL
Also known as: MIRN1225
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38.p13 Ensembl162,090,195 - 2,090,284 (-)EnsemblGRCh38hg38GRCh38
GRCh38162,090,195 - 2,090,284 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh37162,140,196 - 2,140,285 (-)NCBIGRCh37GRCh37hg19GRCh37
Celera162,352,309 - 2,352,398 (-)NCBI
Cytogenetic Map16p13.3NCBI
HuRef162,064,924 - 2,065,013 (-)NCBIHuRef
CHM1_1162,140,111 - 2,140,200 (-)NCBICHM1_1
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
References

References - curated
1. RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:16381832   PMID:17964270   PMID:23861881   PMID:26208314   PMID:26684358   PMID:29881991   PMID:30138106   PMID:30990343   PMID:31288899   PMID:31765229   PMID:32720731   PMID:32901864  
PMID:33577030  


Genomics

Position Markers
GDB:641995  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37162,140,523 - 2,140,920UniSTSGRCh37
Build 36162,080,524 - 2,080,921RGDNCBI36
Celera162,352,636 - 2,353,033RGD
Cytogenetic Map16p13.3UniSTS
HuRef162,065,251 - 2,065,648UniSTS

miRNA Target Status

Confirmed Targets
Gene TargetMature miRNAMethod NameResult TypeData TypeSupport TypePMID
PARP1hsa-miR-1225-3pMirtarbaseexternal_infoCLASHFunctional MTI (Weak)23622248
WDR77hsa-miR-1225-5pMirtarbaseexternal_infoCLASHFunctional MTI (Weak)23622248

Predicted Targets
Summary Value
Count of predictions:54378
Count of gene targets:19014
Count of transcripts:46373
Interacting mature miRNAs:hsa-miR-1225-3p, hsa-miR-1225-5p
Prediction methods:Microtar, Miranda, Pita, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage
High
Medium
Low 400 328 290 25 80 15 489 231 722 20 229 205 11 174 311
Below cutoff 442 327 199 75 118 51 467 345 559 27 133 112 24 173 281

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000408729
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl162,090,195 - 2,090,284 (-)Ensembl
RefSeq Acc Id: NR_030646
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38162,090,195 - 2,090,284 (-)NCBI
GRCh37162,140,196 - 2,140,285 (-)RGD
Celera162,352,309 - 2,352,398 (-)RGD
HuRef162,064,924 - 2,065,013 (-)ENTREZGENE
CHM1_1162,140,111 - 2,140,200 (-)NCBI
Sequence:

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3 copy number gain See cases [RCV000052367] Chr16:23141..11296695 [GRCh38]
Chr16:73141..11390552 [GRCh37]
Chr16:13141..11298053 [NCBI36]
Chr16:16p13.3-13.13
pathogenic
GRCh38/hg38 16p13.3(chr16:29941-2560460)x3 copy number gain See cases [RCV000052368] Chr16:29941..2560460 [GRCh38]
Chr16:79941..2610461 [GRCh37]
Chr16:19941..2550462 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:46766-3214623)x3 copy number gain See cases [RCV000052370] Chr16:46766..3214623 [GRCh38]
Chr16:96766..3264623 [GRCh37]
Chr16:36766..3204624 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:1221651-2233773)x3 copy number gain See cases [RCV000052373] Chr16:1221651..2233773 [GRCh38]
Chr16:1271651..2283774 [GRCh37]
Chr16:1211652..2223775 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3(chr16:2089462-2092132)x1 copy number loss See cases [RCV000051976] Chr16:2089462..2092132 [GRCh38]
Chr16:2139463..2142133 [GRCh37]
Chr16:2079464..2082134 [NCBI36]
Chr16:16p13.3
likely pathogenic|uncertain significance
GRCh38/hg38 16p13.3(chr16:2089647-2096105)x1 copy number loss See cases [RCV000051997] Chr16:2089647..2096105 [GRCh38]
Chr16:2139648..2146106 [GRCh37]
Chr16:2079649..2086107 [NCBI36]
Chr16:16p13.3
likely pathogenic|uncertain significance
NC_000016.10:g.(?_2058737)_(2093096_?)del deletion Tuberous sclerosis 2 [RCV001032849] Chr16:2108738..2143097 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3 copy number gain See cases [RCV000133780] Chr16:46766..11525516 [GRCh38]
Chr16:96766..11619372 [GRCh37]
Chr16:36766..11526873 [NCBI36]
Chr16:16p13.3-13.13
pathogenic
GRCh38/hg38 16p13.3(chr16:1850978-2116369)x3 copy number gain See cases [RCV000135695] Chr16:1850978..2116369 [GRCh38]
Chr16:1900979..2166370 [GRCh37]
Chr16:1840980..2106371 [NCBI36]
Chr16:16p13.3
uncertain significance
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3 copy number gain See cases [RCV000136687] Chr16:46766..4247185 [GRCh38]
Chr16:96766..4297186 [GRCh37]
Chr16:36766..4237187 [NCBI36]
Chr16:16p13.3
pathogenic
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3 copy number gain See cases [RCV000139166] Chr16:43732..13326806 [GRCh38]
Chr16:93732..13420663 [GRCh37]
Chr16:33732..13328164 [NCBI36]
Chr16:16p13.3-13.12
pathogenic
GRCh38/hg38 16p13.3(chr16:2084201-2092088)x3 copy number gain See cases [RCV000140346] Chr16:2084201..2092088 [GRCh38]
Chr16:2134202..2142089 [GRCh37]
Chr16:2074203..2082090 [NCBI36]
Chr16:16p13.3
uncertain significance
GRCh38/hg38 16p13.3-13.11(chr16:666662-15743104)x3 copy number gain See cases [RCV000143710] Chr16:666662..15743104 [GRCh38]
Chr16:716662..15836961 [GRCh37]
Chr16:656663..15744462 [NCBI36]
Chr16:16p13.3-13.11
pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 copy number gain See cases [RCV000203445] Chr16:102839..28327676 [GRCh37]
Chr16:16p13.3-11.2
pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 copy number gain Ductal breast carcinoma [RCV000207053] Chr16:1279324..31926800 [GRCh37]
Chr16:16p13.3-11.2
uncertain significance
GRCh37/hg19 16p13.3-12.3(chr16:1274615-19073133)x3 copy number gain Ductal breast carcinoma [RCV000207326] Chr16:1274615..19073133 [GRCh37]
Chr16:16p13.3-12.3
uncertain significance
NM_001009944.3(PKD1):c.12444+15G>C single nucleotide variant not specified [RCV000248326] Chr16:2090270 [GRCh38]
Chr16:2140271 [GRCh37]
Chr16:16p13.3
likely benign
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 copy number gain See cases [RCV000446684] Chr16:69193..90274381 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448) copy number gain See cases [RCV000446555] Chr16:78801..9169448 [GRCh37]
Chr16:16p13.3-13.2
pathogenic
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3 copy number gain See cases [RCV000445663] Chr16:97133..5122974 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001009944.3(PKD1):c.12445-2A>C single nucleotide variant Polycystic kidney disease [RCV000499768] Chr16:2090196 [GRCh38]
Chr16:2140197 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:643377-3125125)x3 copy number gain See cases [RCV000510815] Chr16:643377..3125125 [GRCh37]
Chr16:16p13.3
uncertain significance
maternal UPD(16p) complex Hemimegalencephaly [RCV000494707] Chr16:1280042..33710558 [GRCh37]
Chr16:16p13.3-11.2
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 copy number gain See cases [RCV000512138] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
NC_000016.9:g.2127606_2334390dup duplication Endometrial carcinoma [RCV000588521] Chr16:2077605..2284389 [GRCh38]
Chr16:2127606..2334390 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3 copy number gain See cases [RCV000510698] Chr16:85880..9883129 [GRCh37]
Chr16:16p13.3-13.2
pathogenic
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3 copy number gain See cases [RCV000512194] Chr16:85880..19806921 [GRCh37]
Chr16:16p13.3-12.3
pathogenic
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 copy number gain See cases [RCV000511360] Chr16:85880..22442007 [GRCh37]
Chr16:16p13.3-12.2
pathogenic
NC_000016.9:g.(?_2098597)_(2150587_?)del deletion Tuberous sclerosis 2 [RCV000525326] Chr16:2098597..2150587 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2086173)_(2112493_?)del deletion Tuberous sclerosis 2 [RCV000644423] Chr16:2086173..2112493 [GRCh38]
Chr16:2136174..2162494 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) copy number gain See cases [RCV000511296] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
Single allele duplication not provided [RCV000677977] Chr16:2134202..2527088 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-3216551)x3 copy number gain not provided [RCV000683742] Chr16:85880..3216551 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1734363-2285561)x1 copy number loss not provided [RCV000683746] Chr16:1734363..2285561 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3 copy number gain not provided [RCV000683743] Chr16:85880..11209288 [GRCh37]
Chr16:16p13.3-13.13
pathogenic
GRCh37/hg19 16p13.3(chr16:1505184-4415346)x3 copy number gain not provided [RCV000683745] Chr16:1505184..4415346 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001009944.3(PKD1):c.12445-2A>T single nucleotide variant not provided [RCV000681717] Chr16:2090196 [GRCh38]
Chr16:2140197 [GRCh37]
Chr16:16p13.3
likely pathogenic
NC_000016.10:g.(?_2079012)_(2092208_?)del deletion Tuberous sclerosis 2 [RCV000707792] Chr16:2079012..2092208 [GRCh38]
Chr16:2129013..2142209 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2048596)_(2106697_?)del deletion Tuberous sclerosis 2 [RCV000708278] Chr16:2048596..2106697 [GRCh38]
Chr16:2098597..2156698 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2055382)_(2119398_?)del deletion Tuberous sclerosis 2 [RCV000708429] Chr16:2055382..2119398 [GRCh38]
Chr16:2105383..2169399 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2053322)_(2092208_?)del deletion Tuberous sclerosis 2 [RCV000708500] Chr16:2053322..2092208 [GRCh38]
Chr16:2103323..2142209 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 copy number gain not provided [RCV000738918] Chr16:88165..90274695 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 copy number gain not provided [RCV000738915] Chr16:61451..90294632 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 copy number gain not provided [RCV000738917] Chr16:88165..90163275 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3(chr16:1807896-2311160)x3 copy number gain not provided [RCV000738986] Chr16:1807896..2311160 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:1813658-2319717)x3 copy number gain not provided [RCV000738989] Chr16:1813658..2319717 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2132731-2218079)x3 copy number gain not provided [RCV000738995] Chr16:2132731..2218079 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2132731-2294549)x3 copy number gain not provided [RCV000738996] Chr16:2132731..2294549 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2132731-2311160)x3 copy number gain not provided [RCV000738997] Chr16:2132731..2311160 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2133701-2319717)x3 copy number gain not provided [RCV000738998] Chr16:2133701..2319717 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2137917-2144182)x1 copy number loss not provided [RCV000738999] Chr16:2137917..2144182 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2138508-2240341)x3 copy number gain not provided [RCV000739000] Chr16:2138508..2240341 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2121778-2143849)x1 copy number loss not provided [RCV000751523] Chr16:2121778..2143849 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2130190-2301527)x3 copy number gain not provided [RCV000751524] Chr16:2130190..2301527 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2130190-2311160)x3 copy number gain not provided [RCV000751525] Chr16:2130190..2311160 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2130190-2319717)x3 copy number gain not provided [RCV000751526] Chr16:2130190..2319717 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2130243-2228644)x3 copy number gain not provided [RCV000751527] Chr16:2130243..2228644 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2130259-2319717)x3 copy number gain not provided [RCV000751528] Chr16:2130259..2319717 [GRCh37]
Chr16:16p13.3
benign
NC_000016.10:g.(?_2048596)_(2135709_?)del deletion Tuberous sclerosis 2 [RCV001033700] Chr16:2098597..2185710 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2048596)_(2111891_?)del deletion Tuberous sclerosis 2 [RCV001033829] Chr16:2098597..2161892 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2072829)_(2119398_?)del deletion Tuberous sclerosis 2 [RCV001032722] Chr16:2122830..2169399 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:109978-4316797) copy number gain Chromosome 16p13.3 duplication syndrome [RCV000767731] Chr16:109978..4316797 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2048596)_(2119398_?)del deletion Tuberous sclerosis 2 [RCV000800659] Chr16:2048596..2119398 [GRCh38]
Chr16:2098597..2169399 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2081575)_(2104662_?)del deletion Tuberous sclerosis 2 [RCV000805913] Chr16:2081575..2104662 [GRCh38]
Chr16:2131576..2154663 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:2070917-2592737)x3 copy number gain not provided [RCV000845878] Chr16:2070917..2592737 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_624055)_(2148005_?)del deletion Tuberous sclerosis 2 [RCV001033183] Chr16:624055..2148005 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2065509)_(2093096_?)dup duplication Tuberous sclerosis 2 [RCV001033344] Chr16:2115510..2143097 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.10:g.(?_2039924)_(2093096_?)dup duplication not provided [RCV001032498] Chr16:2089925..2143097 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_624055)_(2550979_?)dup duplication Idiopathic generalized epilepsy [RCV001033790] Chr16:624055..2550979 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.10:g.(?_2039924)_(2093096_?)del deletion Tuberous sclerosis 2 [RCV001386091]|not provided [RCV001032167] Chr16:2089925..2143097 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.10:g.(?_2048596)_(2098004_?)del deletion Tuberous sclerosis 2 [RCV001033917] Chr16:2098597..2148005 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_1203718)_(2185710_?)del deletion Tuberous sclerosis 2 [RCV001033886] Chr16:1203718..2185710 [GRCh37]
Chr16:16p13.3
pathogenic
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3 copy number gain not provided [RCV001537890] Chr16:84485..5251013 [GRCh37]
Chr16:16p13.3
pathogenic
NM_001009944.3(PKD1):c.12444+1G>A single nucleotide variant Polycystic kidney disease [RCV001292153]|Polycystic kidney disease, adult type [RCV001251474] Chr16:2090284 [GRCh38]
Chr16:2140285 [GRCh37]
Chr16:16p13.3
pathogenic|uncertain significance
NM_001009944.3(PKD1):c.12444+17dup duplication Autosomal dominant polycystic kidney disease [RCV001254207] Chr16:2090261..2090262 [GRCh38]
Chr16:2140262..2140263 [GRCh37]
Chr16:16p13.3
benign
GRCh37/hg19 16p13.3(chr16:2011148-2161281)x3 copy number gain not provided [RCV001259758] Chr16:2011148..2161281 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3 copy number gain not provided [RCV001259749] Chr16:85880..5249457 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_2098597)_(2550979_?)dup duplication Epileptic encephalopathy, early infantile, 1 [RCV001308310] Chr16:2098597..2550979 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_624055)_(2153916_?)dup duplication Epilepsy [RCV001344085]|Idiopathic generalized epilepsy [RCV001316565] Chr16:624055..2153916 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.10:g.(?_2039924)_(2093096_?)dup duplication Tuberous sclerosis 2 [RCV001318970]|not provided [RCV001032498] Chr16:2089925..2143097 [GRCh37]
Chr16:16p13.3
uncertain significance
NC_000016.9:g.(?_2114263)_(2141185_?)dup duplication Tuberous sclerosis 2 [RCV001318972] Chr16:2114263..2141185 [GRCh37]
Chr16:16p13.3
uncertain significance
GRCh37/hg19 16p13.3(chr16:2089795-2185919) copy number loss Polycystic kidney disease, adult type [RCV001535972] Chr16:2089795..2185919 [GRCh37]
Chr16:16p13.3
pathogenic
NC_000016.9:g.(?_2103323)_(2185710_?)del deletion Tuberous sclerosis 2 [RCV001381343] Chr16:2103323..2185710 [GRCh37]
Chr16:16p13.3
pathogenic

Additional Information

Database Acc Id Source(s)
COSMIC MIR1225 COSMIC
Ensembl Genes ENSG00000221656 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000408729 ENTREZGENE
GTEx ENSG00000221656 GTEx
HGNC ID HGNC:33931 ENTREZGENE
Human Proteome Map MIR1225 Human Proteome Map
miRBase MI0006311 ENTREZGENE
NCBI Gene 100188847 ENTREZGENE
OMIM 611621 OMIM
PharmGKB PA164722368 PharmGKB
RNAcentral URS00006DAE80 RNACentral
  URS000075D0F5 RNACentral
  URS000075D62D RNACentral